Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Savaskan

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Nature Medicine|May 13, 2008
Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edemaNicolai E Savaskan, Alexandra Heckel, Eric Hahnen, et al.
Scientific Reports|July 22, 2015
A new functional classification system (FGA/B) with prognostic value for glioma patientsKatharina Friedlein, Yavor Bozhkov, Nirjhar Hore, et al.
Molecular and Cellular Neurosciences|February 16, 2000
Sema3C and netrin-1 differentially affect axon growth in the hippocampal formationA Steup, M Lohrum, N Hamscho, et al.
Scientific Reports|September 18, 2014
Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibrationInes M L Wolf, Zheng Fan, Manfred Rauh, et al.
Cancer Science|December 3, 2014
Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironmentGökçe Hatipoglu, Stefan W Hock, Ruth Weiss, et al.
Oncogene|May 10, 2016
MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesisA Ghoochani, M A Schwarz, E Yakubov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitisOrhan Aktas, Timour Prozorovski, Alina Smorodchenko, et al.
Cancer Medicine|June 6, 2014
The impact of dietary isoflavonoids on malignant brain tumorsTina Sehm, Zheng Fan, Ruth Weiss, et al.
Aging|October 17, 2016
Plasticity Related Gene 3 (PRG3) overcomes myelin-associated growth inhibition and promotes functional recovery after spinal cord injuryThomas Broggini, Lisa Schnell, Ali Ghoochani, et al.
Molecular Cancer Therapeutics|May 30, 2006
Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275Ilker Y Eyüpoglu, Eric Hahnen, Christian Tränkle, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Nature Medicine|May 13, 2008
Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edemaNicolai E Savaskan, Alexandra Heckel, Eric Hahnen, et al.
Scientific Reports|July 22, 2015
A new functional classification system (FGA/B) with prognostic value for glioma patientsKatharina Friedlein, Yavor Bozhkov, Nirjhar Hore, et al.
Molecular and Cellular Neurosciences|February 16, 2000
Sema3C and netrin-1 differentially affect axon growth in the hippocampal formationA Steup, M Lohrum, N Hamscho, et al.
Scientific Reports|September 18, 2014
Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibrationInes M L Wolf, Zheng Fan, Manfred Rauh, et al.
Cancer Science|December 3, 2014
Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironmentGökçe Hatipoglu, Stefan W Hock, Ruth Weiss, et al.
Oncogene|May 10, 2016
MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesisA Ghoochani, M A Schwarz, E Yakubov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitisOrhan Aktas, Timour Prozorovski, Alina Smorodchenko, et al.
Cancer Medicine|June 6, 2014
The impact of dietary isoflavonoids on malignant brain tumorsTina Sehm, Zheng Fan, Ruth Weiss, et al.
Aging|October 17, 2016
Plasticity Related Gene 3 (PRG3) overcomes myelin-associated growth inhibition and promotes functional recovery after spinal cord injuryThomas Broggini, Lisa Schnell, Ali Ghoochani, et al.
Molecular Cancer Therapeutics|May 30, 2006
Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275Ilker Y Eyüpoglu, Eric Hahnen, Christian Tränkle, et al.
Pageof 9